Liquidia Technologies Inc. Announces Extension of Collaboration With PATH to Develop Next Generation Pneumococcal Vaccine
5/21/2013 9:57:55 AM
More...
|
PATH Release: Kala-azar Treatment Completes Phase 3(b) Clinical Trial in Bangladesh
12/17/2012 9:42:09 AM
More...
|
PATH's Drug Development Program Announces Positive Phase 1 Results for Its Anti-Diarrheal Medication
11/12/2012 10:00:59 AM
More...
|
Novavax, Inc. (NVAX) and PATH Announce Partnership on RSV Vaccine
7/18/2012 9:23:28 AM
More...
|
PATH, Abbott Laboratories (ABT) and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition
11/3/2011 12:44:51 PM
More...
|
Infectious Disease Research Institute (IDRI) and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines
6/25/2010 11:05:27 AM
More...
|
BioDiem Ltd. (BDM.AX) Agreement with PATH for Prototype Pandemic Influenza Vaccine
9/1/2009 4:00:36 PM
More...
|
Profectus BioSciences, Inc. Enters into Research Collaboration Agreement with the PATH Malaria Vaccine Initiative (MVI)
8/25/2009 8:58:06 AM
More...
|
GenVec Inc. (GNVC) Expands Contract Supporting Malaria Vaccine Program
7/27/2009 9:26:07 AM
More...
|
Neugenesis Corporation And PATH Sign Collaboration Agreement to Develop an Influenza Vaccine Production System
7/7/2009 9:04:09 AM
More...
|
|